GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Marksans Pharma Ltd (NSE:MARKSANS) » Definitions » Dividend Payout Ratio

Marksans Pharma (NSE:MARKSANS) Dividend Payout Ratio : 0.00 (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Marksans Pharma Dividend Payout Ratio?

Marksans Pharma's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Marksans Pharma's Dividend Payout Ratio or its related term are showing as below:

NSE:MARKSANS' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.02   Med: 0.04   Max: 0.55
Current: 0.07


During the past 13 years, the highest Dividend Payout Ratio of Marksans Pharma was 0.55. The lowest was 0.02. And the median was 0.04.

NSE:MARKSANS's Dividend Payout Ratio is ranked better than
96.03% of 428 companies
in the Drug Manufacturers industry
Industry Median: 0.335 vs NSE:MARKSANS: 0.07

As of today (2024-05-13), the Dividend Yield % of Marksans Pharma is 0.31%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Marksans Pharma was 0.82%. The lowest was 0.09%. And the median was 0.24%.

Marksans Pharma's Dividends per Share for the months ended in Dec. 2023 was ₹0.00.

During the past 12 months, Marksans Pharma's average Dividends Per Share Growth Rate was 100.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 71.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 47.40% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Marksans Pharma was 71.00% per year. The lowest was -25.30% per year. And the median was 2.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Marksans Pharma Dividend Payout Ratio Historical Data

The historical data trend for Marksans Pharma's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marksans Pharma Dividend Payout Ratio Chart

Marksans Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.02 0.02 0.06 0.04

Marksans Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.33 - -

Competitive Comparison of Marksans Pharma's Dividend Payout Ratio

For the Drug Manufacturers - General subindustry, Marksans Pharma's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marksans Pharma's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Marksans Pharma's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Marksans Pharma's Dividend Payout Ratio falls into.



Marksans Pharma Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Marksans Pharma's Dividend Payout Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2023 )/ EPS without NRI (A: Mar. 2023 )
=0.25/ 6.891
=0.04

Marksans Pharma's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ 1.84
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marksans Pharma (NSE:MARKSANS) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Marksans Pharma Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Marksans Pharma's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Marksans Pharma (NSE:MARKSANS) Business Description

Traded in Other Exchanges
Address
Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.

Marksans Pharma (NSE:MARKSANS) Headlines

No Headlines